Long-term Debt and Lease Obligation of Keenova Therapeutics plc from 28 Sep 2012 to 26 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of long-term debt and lease obligation, classified as noncurrent.
Summary
Keenova Therapeutics plc quarterly Long-term Debt and Lease Obligation in USD history and change rate from 28 Sep 2012 to 26 Sep 2025.
  • Keenova Therapeutics plc Long-term Debt and Lease Obligation for the quarter ending 26 Sep 2025 was $3,690,600,000, a 113% increase year-over-year.
Source SEC data
View on sec.gov
Long-term Debt and Lease Obligation, Quarterly (USD)
Long-term Debt and Lease Obligation, YoY Quarterly Change (%)

Keenova Therapeutics plc Quarterly Long-term Debt and Lease Obligation (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,690,600,000 +$1,958,800,000 +113% 26 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $901,400,000 -$838,400,000 -48% 27 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $905,400,000 -$842,500,000 -48% 28 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $909,500,000 -$846,400,000 -48% 27 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $1,731,800,000 +$1,731,800,000 27 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 $1,739,800,000 +$1,002,200,000 +136% 28 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $1,747,900,000 -$1,293,700,000 -43% 29 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $1,755,900,000 -$1,271,800,000 -42% 29 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $0 -$3,034,300,000 -100% 29 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $737,600,000 -$2,287,900,000 -76% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $3,041,600,000 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $3,027,700,000 +$3,027,700,000 30 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 $3,034,300,000 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $3,025,500,000 01 Jul 2022 10-Q 11 Aug 2022 2022 Q2
Q4 2021 $0 $0 31 Dec 2021 10-K 03 Mar 2023 2022 FY
Q4 2020 $0 -$4,741,200,000 -100% 25 Dec 2020 10-K 10 Mar 2021 2020 FY
Q3 2020 $0 -$5,048,700,000 -100% 25 Sep 2020 10-Q 03 Nov 2020 2020 Q2
Q2 2020 $5,223,400,000 +$400,400,000 +8.3% 26 Jun 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 $4,739,100,000 -$1,078,500,000 -19% 27 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $4,741,200,000 -$1,328,000,000 -22% 27 Dec 2019 10-K 10 Mar 2021 2020 FY
Q3 2019 $5,048,700,000 -$1,125,300,000 -18% 27 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $4,823,000,000 -$1,512,100,000 -24% 28 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $5,817,600,000 -$673,900,000 -10% 29 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $6,069,200,000 -$351,700,000 -5.5% 28 Dec 2018 10-K 26 Feb 2020 2019 FY
Q3 2018 $6,174,000,000 +$656,600,000 +12% 28 Sep 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 $6,335,100,000 +$996,600,000 +19% 29 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 $6,491,500,000 +$791,600,000 +14% 30 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 $6,420,900,000 +$540,100,000 +9.2% 29 Dec 2017 10-K 26 Feb 2019 2018 FY
Q3 2017 $5,517,400,000 -$271,300,000 -4.7% 29 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 $5,338,500,000 -$940,500,000 -15% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 $5,699,900,000 -$709,700,000 -11% 31 Mar 2017 10-Q 08 May 2017 2017 Q1
Q4 2016 $5,880,800,000 -$528,800,000 -8.2% 30 Dec 2016 10-K 27 Feb 2018 2017 FY
Q3 2016 $5,788,700,000 -$685,600,000 -11% 30 Sep 2016 10-QT 07 Feb 2017 2016 Q4
Q2 2016 $6,279,000,000 +$945,900,000 +18% 24 Jun 2016 10-Q 02 Aug 2016 2016 Q3
Q1 2016 $6,409,600,000 +$2,443,300,000 +62% 25 Mar 2016 10-Q 03 May 2016 2016 Q2
Q4 2015 $6,409,600,000 +$2,467,400,000 +63% 25 Dec 2015 10-Q 02 Feb 2016 2016 Q1
Q3 2015 $6,474,300,000 +$2,600,300,000 +67% 25 Sep 2015 10-K 29 Nov 2016 2016 FY
Q2 2015 $5,333,100,000 +$3,131,800,000 +142% 26 Jun 2015 10-Q 04 Aug 2015 2015 Q3
Q1 2015 $3,966,300,000 +$1,761,600,000 +80% 27 Mar 2015 10-Q 05 May 2015 2015 Q2
Q4 2014 $3,942,200,000 +$3,024,200,000 +329% 26 Dec 2014 10-Q 03 Feb 2015 2015 Q1
Q3 2014 $3,874,000,000 +$2,955,700,000 +322% 26 Sep 2014 10-K 24 Nov 2015 2015 FY
Q2 2014 $2,201,300,000 +$1,282,800,000 +140% 27 Jun 2014 10-Q 07 Aug 2014 2014 Q3
Q1 2014 $2,204,700,000 28 Mar 2014 10-Q 08 May 2014 2014 Q2
Q4 2013 $918,000,000 27 Dec 2013 10-Q 07 Feb 2014 2014 Q1
Q3 2013 $918,300,000 +$909,400,000 +10218% 27 Sep 2013 8-K 03 Apr 2015 2014 FY
Q2 2013 $918,500,000 28 Jun 2013 10-Q 12 Aug 2013 2013 Q3
Q3 2012 $8,900,000 28 Sep 2012 10-K 13 Dec 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.